Slomovitz BM, Cibula D, Lv W, Ortaç F, Hietanen S, Backes F, Kikuchi A, Lorusso D, Danska-Bidzinska A, Samouëlian V, Barretina-Ginesta MP, Vulsteke C, Lai CH, Pothuri B, Zhang Y, Magallanes-Maciel M, Amit A, Guarneri V, Zagouri F, Bell M, Welz J, Eminowicz G, Hruda M, J Willmott L, Lichfield J, Wang W, Orlowski R, Aktan G, Gladieff L, Van Gorp T
Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without Radiotherapy For Newly Diagnosed, High-Risk Endometrial Cancer: Results in Mismatch Repair-Deficient Tumors.
Perez-Fidalgo A, Schmalfeldt B, George A, Gourley C, Pignata S, Lorusso D, Barretina-Ginesta MP, Romero I, Grimm C, Van Gorp T, Rossing M, Collins DC, Fernebro J, Bjørge L, Leary A, de la Motte Rouge T, Harter P, Kurzeder C, Savva-Bordalo J, You B
Consensus on drivers of maintenance treatment choice and patterns of care in advanced ovarian cancer.
Barretina-Ginesta, MP, Gil-Martin, M, Vaswani, AR, Sanchez-Heras, AB, Churruca, C, Guerra-Alía, EM, Madroñal, C, Fernández-Plana, J, Herrero, A, Dotor, E, Esteban, C, Quindós, M, Romeo, M, Gost, E, Bermejo, MJ, Fernandez-Chacón, C, Ferrer, N, Gómez-Raposo, C, Catot, S, Madariaga, A
Addressing Unmet Aftercare Needs In Long-Term Survivors Of Ovarian Cancer: Insights From A Spanish Cohort Of The ENGOTOv40/GEICO 71-R/Expression VI Survey
Harano, K, Fossati, R, Pardo, B, Galli, F, Hudson, E, Antill, Y, Lee, C, Rabaglio, M, Heitz, F, Kolovetsiou-Kreiner, V, Lai, CH, Biagioli, E, Manso, L, Nishio, S, Allan, K, Lee, YC, Uggeri, S, Redondo, A, Nakagawa, S, Au, E, Lombard, J, Gadducci, A, Takehara, K, Baldini, EE, Palaia, I, Casanova, C, Ardizzoia, A, Bologna, A, Barretina-Ginesta, MP, Colombo, N
Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma: the Asian cohort of the AtTEnd/ENGOT-EN7 trial
